Peter Soliz, PhD
CEO, Chairman & Founder
Peter Soliz, PhD, has more than 20 years of experience in the management of software development for medical devices. His past collaborators include well-known research physicians from the University of Iowa Department of Ophthalmology and Visual Sciences, the University of Wisconsin Reading Center and the University of New Mexico Health Sciences Center. Under his leadership, VisionQuest i-Rx has secured millions in research funding from the National Institutes of Health and established a diabetic retinopathy screening business in the United States and Mexico. Dr. Soliz is the driving force behind the VisionQuest i-Rx initiative to form strategic partnerships and engage investors in the company. A recognized expert in retinal imaging devices, he holds several patents on this technology. Dr. Soliz is now focused on revolutionizing retinal diagnostics via automatic image interpretation software intended to support early diagnosis, increase access and patient compliance, and reduce the cost of care. Soliz earned his PhD from the University of Oklahoma and after a career in U.S. Air Force Laboratories, he focused his career on developing innovative medical devices.
Simon Barriga, PhD
President & Chief Research Scientist
Simon Barriga, PhD, is the principal scientist and engineer behind the development of the VisionQuest i-Rx’ EYESTAR+™ automated diabetic retinopathy reading system. He has dedicated 15 years to the development, testing, implementation, and now commercialization of the automated reading system software. Dr. Barriga and his team have developed multiple algorithms for retinal image analysis. These include software for automatically determining the quality of retinal images and for automatically detecting diabetic retinopathy. He earned his PhD from the University of New Mexico.
Wendall C. Bauman, Jr., MD
Chief Medical Officer
Wendall Bauman, Jr., MD, is VisionQuest i-Rx’s chief medical officer and has served as the medical director of VisionQuest Biomedical since 2009. A retinal specialist for three decades, Dr. Bauman is actively involved in VisionQuest i-Rx’s research and clinical translation. His expertise in automatic retinal screening and telemedicine has been invaluable during the development and commercialization of EYESTAR™. Dr. Bauman also serves as VisionQuest i-Rx’ Board of Directors on matters concerning clinical applications and the FDA. He attended the Uniformed Serves University of the Health Sciences in Bethesda, Maryland and earned his MD in 1983. During his career in the U.S. Air Force, he was a retinal specialist and chief of Ophthalmology at Brooke Army Medical Center, where he did extensive research on retinal disease. In the early 1990s, Bauman initiated a retinal-screening program for all Air Force personnel. He has served the population of South Texas for nearly 20 years, practicing at three sites in South Texas. Board certified in Ophthalmology, Dr. Bauman treats diseases of the retina, vitreous and uveitis.
Gilberto Zamora, PhD
Director of Clinical Operations
Gilberto Zamora, PhD, oversees VisionQuest i-Rx’ clinical operations that include clinical validation and efforts to establish commercial screening networks. He successfully implemented retinal screening at a network of diabetes clinics in New Mexico, Texas and Mexico. Additionally, under Dr. Zamora’s direction, VisionQuest i-Rx’s automated diabetic retinopathy reading system is currently in use in Mexico, demonstrating safety and effectiveness of the automatic eye screening software in a clinical environment. Dr. Zamora earned his PhD from Texas Tech University.